Table 2.
Demographics and baseline parameters in experiment 2
| Measurement Unit | PAD | PAD Range | Healthy | Healthy Range | P |
|---|---|---|---|---|---|
| Men/Women | 5/2 | 5/2 | |||
| Age, yr | 64 ± 3 | 52–74 | 64 ± 3 | 51–75 | 0.940 |
| Height, m | 1.69 ± 0.04 | 1.52–1.85 | 1.74 ± 0.04 | 1.60–1.82 | 0.407 |
| Weight, kg | 80.7 ± 5.2 | 62.8–102.0 | 75.5 ± 4.5 | 57.7–87.6 | 0.476 |
| Body mass index, kg/m2 | 28.2 ± 1.6 | 21.9–34.2 | 25.6 ± 1.0 | 22.5–29.5 | 0.226 |
| ABI least symptomatic | 0.87 ± 0.02* | 0.76–0.96 | 1.00 ± 0.04 | 0.91–1.16 | 0.019 |
| ABI most symptomatic | 0.69 ± 0.03* | 0.60–0.83 | 1.04 ± 0.04 | 0.92–1.23 | <0.001 |
| Systolic blood pressure, mmHg | 129 ± 7 | 111–168 | 115 ± 4 | 101–128 | 0.128 |
| Diastolic blood pressure, mmHg | 75 ± 3 | 68–91 | 75 ± 3 | 64–83 | 0.688 |
| Mean arterial pressure, mmHg | 92 ± 3 | 84–106 | 87 ± 3 | 76–94 | 0.250 |
| Heart rate, beats/min | 65 ± 4 | 53–78 | 63 ± 5 | 50–87 | 0.722 |
| ATT, mm | 4.42 ± 0.50 | 3.07–6.98 | 5.87 ± 0.44 | 4.08–6.79 | 0.055 |
| Calf circumference, cm | 33.4 ± 0.7 | 30.5–35.4 | 34.6 ± 1.0 | 32.0–39.0 | 0.334 |
| Lesion location | |||||
| Aortoiliac | 1 | ||||
| Femoropopliteal | 4 | ||||
| Infrapopliteal | 2 | ||||
| Mutiple | 4 | ||||
| Medications | |||||
| Anticoagulants | 3 | ||||
| Antiaggregants | 5 | ||||
| Statins | 3 | ||||
| Antihypertensives | 4 | ||||
| β-Blockers | 2 | ||||
| Drugs labeled for PAD | 0 |
Values are means ± SE and also as min-max values.
ABI, ankle brachial index; ATT, adipose tissue thickness over medial gastrocnemius; PAD, peripheral artery disease.
*
P < 0.05 compared with healthy subjects were obtained with independent samples via t-test.